EGATERIN Canadian Trademark Information

Pharmaceutical preparations for the prevention and/or treatment of disorders of the nervous system, namely encephalitis, epilepsy, Alzheimer's disease, cerebral palsy and Parkinson's disease; pharmaceutical preparations for the prevention and/or treatment of disorders of the immune system, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of disorders of the cardio-vascular system, pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of disorders of the genitourinary system, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the prevention and/or treatment of inflammatory disorders, namely inflammatory bowel diseases and inflammatory connective tissue diseases; pharmaceutical p...

Perfect for these industries

Pharmaceutical Products

Words that describe this mark

pharmaceutical preparations prevention andor treatment disorders nervous encephalitis epilepsy alzheimers disease cerebral palsy parkinsons disease pharmaceutical preparations prevention andor treatment disorders immune autoimmune diseases immunologic deficiency syndromes pharmaceutical preparations prevention andor treatment

Abandonment Notice! On Wednesday, January 28, 2009, status on the EGATERIN trademark changed to Interruption of proceeding. Apply Now for this name starting at $449!

CAUTION: Although Canada registration for this particular filing is inactive, the mark may still enjoy common law rights, or may have been applied for again in a separate application. Further research may be warranted to determine where this mark is truly abandoned in commerce.

On Tuesday, January 7, 2003, a canadian trademark registration was filed for EGATERIN by NOVARTIS AG *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1164022. The current status of this trademark filing is Interruption of proceeding. The EGATERIN trademark is filed in the description of Pharmaceutical preparations for the prevention and/or treatment of disorders of the nervous system, namely encephalitis, epilepsy, Alzheimer's disease, cerebral palsy and Parkinson's disease; pharmaceutical preparations for the prevention and/or treatment of disorders of the immune system, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of disorders of the cardio-vascular system, pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of disorders of the genitourinary system, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the prevention and/or treatment of inflammatory disorders, namely inflammatory bowel diseases and inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely for the treatment of dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases. , Pharmaceutical preparations for the prevention and/or treatment of disorders of the nervous system, namely encephalitis, epilepsy, Alzheimer's disease, cerebral palsy and Parkinson's disease; pharmaceutical preparations for the prevention and/or treatment of disorders of the immune system, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of disorders of the cardio-vascular system, pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of disorders of the genitourinary system, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the prevention and/or treatment of inflammatory disorders, namely inflammatory bowel diseases and inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely for the treatment of dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases. , Pharmaceutical preparations for the prevention and/or treatment of disorders of the nervous system, namely encephalitis, epilepsy, Alzheimer's disease, cerebral palsy and Parkinson's disease; pharmaceutical preparations for the prevention and/or treatment of disorders of the immune system, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of disorders of the cardio-vascular system, pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of disorders of the genitourinary system, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the prevention and/or treatment of inflammatory disorders, namely inflammatory bowel diseases and inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely for the treatment of dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases. .

Get FREE email alerts

100% Satisfaction Guarantee

protect your valuable brand now.

Classification Information

Class Code:	005 - Pharmaceutical Products
Description:	Pharmaceuticals and herbicides

Matter History Events

Status Date	Record Status Description
2009-01-28	Interruption of proceeding - Abandoned - Subsection 40(3)
2008-07-17	National prosecution history entry - Extension of Time
2008-01-08	National prosecution history entry - Extension of Time
2007-07-03	National prosecution history entry - Extension of Time
2007-01-23	National prosecution history entry - Extension of Time
2006-06-22	National prosecution history entry - Extension of Time
2006-02-07	National prosecution history entry - Extension of Time
2004-03-26	National prosecution history entry - Allowed
2004-03-26	National prosecution history entry - Allowance Notice Sent
2004-01-07	Application published - Advertised
2003-11-28	Application accepted - Approved
2003-10-09	National prosecution history entry - Search Recorded
2003-10-09	National prosecution history entry - Examiner's First Report
2003-01-28	Filing date accorded - Formalized
2003-01-10	National prosecution history entry - Created
2003-01-07	Application filed - Filed

Word Mark:	EGATERIN
Current Status:	Interruption of proceeding DEAD Mark! Start a New Filing Request 1/28/2009
Application Number:	1164022
Filing Date:	Tuesday, January 7, 2003
Filing Place:	Canada
Registration Date:	Not Available
Register Type:	Primary
Type Of Mark:	Trademark
Mark Feature:	Word
Use In Commerce:	No
Publication Registration:	Wednesday, January 7, 2004
Opposition:	1/7/2004 - 1/7/2004
Last Applicant/Owner:	NOVARTIS AG ******* ****** * **
Correspondent:	Not provided

Goods and Services Information
Description:	(1) - Pharmaceutical preparations for the prevention and/or treatment of disorders of the nervous system, namely encephalitis, epilepsy, Alzheimer's disease, cerebral palsy and Parkinson's disease; pharmaceutical preparations for the prevention and/or treatment of disorders of the immune system, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of disorders of the cardio-vascular system, pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of disorders of the genitourinary system, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the prevention and/or treatment of inflammatory disorders, namely inflammatory bowel diseases and inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely for the treatment of dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases. (2) - Pharmaceutical preparations for the prevention and/or treatment of disorders of the nervous system, namely encephalitis, epilepsy, Alzheimer's disease, cerebral palsy and Parkinson's disease; pharmaceutical preparations for the prevention and/or treatment of disorders of the immune system, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of disorders of the cardio-vascular system, pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of disorders of the genitourinary system, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the prevention and/or treatment of inflammatory disorders, namely inflammatory bowel diseases and inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely for the treatment of dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases. (3) - Pharmaceutical preparations for the prevention and/or treatment of disorders of the nervous system, namely encephalitis, epilepsy, Alzheimer's disease, cerebral palsy and Parkinson's disease; pharmaceutical preparations for the prevention and/or treatment of disorders of the immune system, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of disorders of the cardio-vascular system, pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of disorders of the genitourinary system, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the prevention and/or treatment of inflammatory disorders, namely inflammatory bowel diseases and inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely for the treatment of dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases.

Perfect for these industries

Words that describe this mark

a canadian trademark registration was filed for by . The Canadian IP office has given the trademark application number of . The current status of this trademark filing is . The correspondent listed for is The trademark is filed in the description of .

Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms! You can register your trademark in 180+ countries in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

100% Satisfaction Guarantee

protect your valuable brand now.

How it works

1. Trademarkia Network Law firm - #1 Trademark Filing since 2010.

2. Describe how your business or product is being used. Register your mark in 180+ countries.

What you get

1. Top Global Specialist - Credibility and Experience!

2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK

How it works

1. Trademarkia Network Law firm - #1 Trademark Filing since 2010.

2. Describe how your business or product is being used. Register your mark in 180+ countries.

What you get

1. Top Global Specialist - Credibility and Experience!

2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK

What You Can Do:

Start Your Business

Get FREE email alerts

Add to Favorites

Start Canada Trademark Filing

Custom Logo Design $99

Search on popular social networks

This mark may be available for re-registration. You can apply for it through Trademarkia at a low cost of $449!

Trademarkia.com will perform a final search in order to verify that this mark is available for Canada Trademark re-registration. All Trademarkia services are backed by a 100% satisfaction guarantee.

Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!

As seen on